These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3585229)

  • 41. D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats.
    De Souza EB; Van Loon GR
    Endocrinology; 1982 Nov; 111(5):1483-90. PubMed ID: 6290184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemorrhage and adrenocortical activity in the fowl (Gallus domesticus).
    Radke WJ; Albasi CM; Harvey S
    Gen Comp Endocrinol; 1985 Nov; 60(2):204-9. PubMed ID: 4065530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of various serotoninergic agonists and an antagonist on a nociceptive reaction in mice.
    Ramabadran K; Jacob JJ
    Jpn J Pharmacol; 1982 Dec; 32(6):1059-65. PubMed ID: 6984472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of cyproheptadine on the regulation of the adrenal system (author's transl)].
    Kley HK; Dehnen H; Krüskemper HL
    Arzneimittelforschung; 1979; 29(6):885-9. PubMed ID: 226103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flumezapine, an antagonist of central dopamine and serotonin receptors.
    Fuller RW; Mason NR
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):23-34. PubMed ID: 2879325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect.
    Malendowicz LK; Nussdorfer GG; Nowak KW; Ziolkowska A; Tortorella C; Trejter M
    Int J Mol Med; 2003 Aug; 12(2):237-41. PubMed ID: 12851724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    Welch JE; Saphier D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE; Farrar GE; Dunn AJ; Saphier D
    Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein malnutrition in the domestic fowl induces alterations in adrenocortical function.
    Carsia RV; Weber H; Lauterio TJ
    Endocrinology; 1988 Feb; 122(2):673-80. PubMed ID: 2828009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
    Sakakura M; Yoshioka M; Kobayashi M; Takebe K
    Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
    Sapun-Malcolm D; Farah JM; Mueller GP
    Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotoninergic involvement in the regulation of circadian rhythms of hypothalamic-pituitary adrenal and prolactin axis.
    Scapagnini U; Nisticò G
    Ann Ist Super Sanita; 1978; 14(1):163-72. PubMed ID: 227305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.